First City Capital Management, Inc. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 316 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
First City Capital Management, Inc. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$253,000
+11.9%
5,305
+38.5%
0.09%
-46.0%
Q2 2020$226,000
-2.2%
3,8300.0%0.17%
+9.4%
Q4 2019$231,000
+0.9%
3,8300.0%0.16%
-4.8%
Q3 2019$229,000
-6.9%
3,8300.0%0.17%
-6.7%
Q2 2019$246,000
-20.9%
3,8300.0%0.18%
-20.1%
Q1 2019$311,000
+8.0%
3,830
-28.1%
0.22%
-0.4%
Q4 2018$288,000
+4.7%
5,3300.0%0.22%
+23.0%
Q3 2018$275,000
+23.9%
5,3300.0%0.18%
+15.1%
Q2 2018$222,000
-5.5%
5,3300.0%0.16%
-9.7%
Q1 2018$235,000
-12.3%
5,3300.0%0.18%
-3.8%
Q4 2017$268,000
-0.7%
5,3300.0%0.18%
-3.2%
Q3 2017$270,000
-0.4%
5,3300.0%0.19%
-4.1%
Q2 2017$271,000
+26.6%
5,3300.0%0.20%
+24.7%
Q1 2017$214,000
-16.1%
5,3300.0%0.16%
-17.7%
Q4 2016$255,000
-99.9%
5,330
+3.9%
0.19%
+35.2%
Q1 2016$207,765,000
-49.7%
5,130
-23.0%
0.14%
-48.7%
Q4 2015$412,763,0006,6650.28%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders